Morning Commentary: Micron Technology weakens again; Acorda convertibles edge up with stock

By Stephanie N. Rotondo

Seattle, July 3 – Micron Technology Inc.’s 3% convertible notes due 2043 remained weak early Monday, following Friday’s sell-off.

A trader called the bonds down 1.5 points around 112.25.

As for the underlying stock (Nasdaq: MU), it was off 55 cents, or 1.84%, to $29.31.

The convertibles – as well as the stock – were pressured on Friday.

Also, Micron released quarterly earnings late Thursday. While the company beat expectations – and raised guidance – concerns about the overall tech space were more in focus.

Micron also said that its share price had triggered a contingent convertible feature on four series of convertible notes, its 2.375% convertible senior notes due 2032, 3.125% convertible senior notes due 2032, 1.625% convertible senior notes due 2033 and 2.125% convertible senior notes due 2033.

Elsewhere, Acorda Therapeutics Inc.’s 1.75% convertible notes due 2021 were “tracking” the stock, a trader reported.

He saw the convertible debt ticking up nearly ˝ point to around 85.875.

As for the company’s common shares (Nasdaq: ACOR), they were up 15 cents at $19.85 at mid-morning.

Last week, it was reported that Acorda had filed a new drug application for its Parkinson’s disease drug. The company had previously announced positive trial results on the treatment, which is being touted as a treatment for off-period symptoms related to the disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.